Table II.

Response to induction therapy and remission status at ASCT

Parameter	All patients n (%)	HyperCVAD (±R) + ASCT in CR1/PR1 n (%)	CHOP (±R) + ASCT in CR1/PR1 n (%)	ASCT with relapsed/refractory disease n (%)
Response to induction therapy
CR/CRu	28 (50)	17 (81)	4 (27)	7 (35)
PR	23 (41)	4 (19)	11 (73)	8 (40)
Other	5 (9)	0 (0)	0 (0)	5 (25)
Remission status at ASCT
CR1/CRu1	23 (41)	18 (86)*	5† (33)	0 (0)
PR1	13 (23)	3 (14)	10 (67)	0 (0)
Other	20 (36)	0 (0)	0 (0)	20 (100)

^*One patient converted from a PR to a CR with chemomobilization prior to stem cell collection.

^†One patient converted from a PR to a CR after receiving 2 cycles of R-HyperCVAD after the initial R-CHOP×4 cycles